SCHEMBL6514622

SCHEMBL6514622

COCCc1[nH]nc2c1c(=O)n(CCC(C)N)c1ccc(Cl)cc21

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 7/20 0.54
MAPK8 P45983 3/20 0.39
MAPK9 P45984 1/20 0.39
MAPK10 P53779 1/20 0.39
PLK1 P53350 4/20 0.38
PTGER4 P35408 1/20 0.33
ALDH1A1 P00352 1/20 0.32
KCNH2 Q12809 1/20 0.32
RET P07949 1/20 0.32
PDGFRB P09619 1/20 0.32
PIM1 P11309 1/20 0.32
CDK2 P24941 1/20 0.32
CDK9 P50750 1/20 0.32
MAP2K1 Q02750 1/20 0.32
MST1R Q04912 1/20 0.32
TYRO3 Q06418 1/20 0.32
NTRK3 Q16288 1/20 0.32
CAMK1D Q8IU85 1/20 0.32
ALK Q9UM73 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6515566 0.94 CHEK1 (0.52) CHEK1MAPK8MAPK9MAPK10PLK1
SCHEMBL6513681 0.87 CHEK1 (0.70) CHEK1MAPK8MAPK9MAPK10PLK1
SCHEMBL6514619 0.85 CHEK1 (0.52) CHEK1MAPK8MAPK9MAPK10PLK1
SCHEMBL6521937 0.85 CHEK1 (0.52) CHEK1MAPK8MAPK9MAPK10PLK1
SCHEMBL6521943 0.85 CHEK1 (0.52) CHEK1MAPK8MAPK9MAPK10PLK1
SCHEMBL6518147 0.83 CHEK1 (0.77) CHEK1PLK1KCNH2
SCHEMBL6519320 0.83 CHEK1 (0.77) CHEK1PLK1KCNH2
SCHEMBL6508146 0.83 CHEK1 (0.77) CHEK1PLK1KCNH2
SCHEMBL6510497 0.83 CHEK1 (0.55) CHEK1MAPK8MAPK9MAPK10PLK1
SCHEMBL6509246 0.83 CHEK1 (0.55) CHEK1MAPK8MAPK9MAPK10PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050245563-A1 Chk-1 inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245563-A1 Chk-1 inhibitors CHKA, CHKB, CHEK1 CHEK1 3/4885MAPK8 391/4885MAPK9 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.